Literature DB >> 11673212

Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture.

L Liaudet1, J G Mabley, F G Soriano, P Pacher, A Marton, G Haskó, C Szabó.   

Abstract

Inosine is a naturally occurring purine formed from the breakdown of adenosine. Here we have evaluated the effects of inosine in a murine model of polymicrobial sepsis induced by cecal ligation and puncture (CLP). Mice subjected to CLP were treated with either inosine (100 mg/kg, intraperitoneally) or vehicle 1 h before and 6 h after CLP. After 12 h tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 were measured in plasma. Biochemical markers of organ damage, liver NAD+/NADH (indicator of the mitochondrial redox state), plasma nitrate, tissue myeloperoxidase (MPO, indicator of neutrophil accumulation) and malondialdehyde (MDA, indicator of lipid peroxidation), liver and lung chemokines (macrophage inflammatory protein 1alpha [MIP-1alpha] and MIP-2), and ex vivo vascular reactivity in aortic rings were also measured. Mice treated with inosine had significantly lower levels of circulating cytokines. Organ damage was significantly reduced by inosine treatment, which was associated at the tissue level with an increased hepatic NAD+/NADH ratio, decreased MPO activity in the lung, reduced MDA formation in the gut and liver, and decreased MIP-1alpha and MIP-2 in the lung and liver. Furthermore, inosine significantly improved endothelium-dependent relaxant responses of aortic rings. These effects were associated with significant improvement of the survival of CLP mice treated with inosine, an effect that was still observed when inosine treatment was delayed 1 h after CLP, especially when it was associated with appropriate antibiotic treatment. Thus, inosine reduced systemic inflammation, organ damage, tissue dysoxia, and vascular dysfunction, resulting in improved survival in septic shock.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673212     DOI: 10.1164/ajrccm.164.7.2101013

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

1.  Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.

Authors:  Zoltán H Németh; Balázs Csóka; Jeanette Wilmanski; Dazhong Xu; Qi Lu; Catherine Ledent; Edwin A Deitch; Pál Pacher; Zoltán Spolarics; György Haskó
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

2.  The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias.

Authors:  Ajith A Welihinda; Manmeet Kaur; Kelly Greene; Yongjiao Zhai; Edward P Amento
Journal:  Cell Signal       Date:  2016-02-19       Impact factor: 4.315

3.  Enhancement of inosine-mediated A2AR signaling through positive allosteric modulation.

Authors:  Ajith A Welihinda; Manmeet Kaur; Kaviya S Raveendran; Edward P Amento
Journal:  Cell Signal       Date:  2017-11-08       Impact factor: 4.315

4.  Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis.

Authors:  Guangliang Hong; Dong Zheng; Lulu Zhang; Rui Ni; Grace Wang; Guo-Chang Fan; Zhongqiu Lu; Tianqing Peng
Journal:  Free Radic Biol Med       Date:  2018-05-24       Impact factor: 7.376

5.  The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury.

Authors:  Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabo
Journal:  Shock       Date:  2009-09       Impact factor: 3.454

6.  The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.

Authors:  Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabo
Journal:  J Endocrinol       Date:  2008-06-18       Impact factor: 4.286

7.  The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.

Authors:  Manuella P Kaster; Josiane Budni; Marta Gazal; Mauricio P Cunha; Adair R S Santos; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2013-04-25       Impact factor: 3.765

8.  Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.

Authors:  Jon G Mabley; Alex Rabinovitch; Wilma Suarez-Pinzon; György Haskó; Pál Pacher; Robert Power; Gary Southan; Andrew Salzman; Csaba Szabó
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

9.  The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock.

Authors:  Gerd Albuszies; Josef Vogt; Ulrich Wachter; Christoph Thiemermann; Xavier M Leverve; Sandra Weber; Michael Georgieff; Peter Radermacher; Eberhard Barth
Journal:  Intensive Care Med       Date:  2007-04-26       Impact factor: 17.440

10.  Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A2A and A 3 receptors.

Authors:  Fernanda da Rocha Lapa; Ana Paula Ligeiro de Oliveira; Beatriz Golega Accetturi; Isabelli de Oliveira Martins; Helory Vanni Domingos; Daniela de Almeida Cabrini; Wothan Tavares de Lima; Adair Roberto Soares Santos
Journal:  Purinergic Signal       Date:  2013-01-26       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.